| Patient | Frances Burney |
|---|---|
| Date of birth | 1967-06-13 |
| Identifiers | MRN HR-EN013-SYN; SSN (made up) 000-13-9108 |
| Document date | 2026-11-01 |
| Author | Harriet Pell, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
Primary care visit for a right breast lump and a year of breast ache. Concerns: A heavy, dull ache in the right breast for about a year and a firm lump she noticed two months ago; Dreads an operation; wants every step explained in advance and to be warned before anything is done. [S]
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|---|---|---|---|---|
| Acetaminophen 500 mg oral tablet, two tablets (1000 mg) by mouth every 6 hours for pain after surgery, no more than 3000 mg a day | Two tablets every 6 hours | Oral route | 2026-09-30 to 2026-10-14 | completed | S |
| Ibuprofen 400 mg oral tablet, one tablet by mouth every 8 hours with food for five days after surgery | One tablet every 8 hours with food | Oral route | 2026-09-30 to 2026-10-05 | completed | S |
| Anastrozole 1 mg oral tablet, one tablet by mouth once daily, planned for five years | One tablet once daily | Oral route | 2026-10-19 | active | S |
| Cholecalciferol (vitamin D3) 1000 units oral tablet, one tablet by mouth once daily | One tablet once daily | Oral route | 2026-10-19 | active | S |
| Procedure | Dates | Status | Evidence |
|---|---|---|---|
| Diagnostic bilateral mammography: 2.4 cm irregular spiculated mass at 10 o'clock in the upper outer right breast; heterogeneously dense breasts; left breast normal; BI-RADS 5 | 2026-08-12 to 2026-08-12 | completed | S |
| Right breast and axillary ultrasound: 2.5 cm irregular hypoechoic mass at 10 o'clock, 6 cm from the nipple; normal axillary lymph nodes | 2026-08-12 to 2026-08-12 | completed | S |
| Ultrasound-guided core needle biopsy of the right breast mass with clip placement: invasive ductal carcinoma, grade 2; ER 95 percent, PR 70 percent, HER2 1+ (negative), Ki-67 15 percent | 2026-08-14 to 2026-08-14 | completed | S |
| Bilateral breast MRI with contrast for extent of disease: index mass 2.6 cm; a second 0.8 cm enhancing mass at 7 o'clock in the right breast, 5 cm from the index mass; left breast normal; no enlarged nodes | 2026-08-28 to 2026-08-28 | completed | S |
| MRI-guided core needle biopsy of the second right breast lesion: invasive ductal carcinoma, grade 2, ER positive, HER2 negative (multicentric disease) | 2026-09-03 to 2026-09-03 | completed | S |
| Right total mastectomy without reconstruction, her choice, under general anesthesia; overnight stay. Pathology: multicentric invasive ductal carcinoma, 2.6 cm and 0.8 cm, grade 2, margins clear, no lymphovascular invasion; pT2(m) pN0(sn), anatomic stage IIA. Recurrence score (21-gene assay) 13 | 2026-09-30 to 2026-09-30 | completed | S |
| Right axillary sentinel lymph node biopsy at mastectomy (radioisotope and blue dye): 0 of 3 nodes involved | 2026-09-30 to 2026-09-30 | completed | S |
| Ultrasound-guided pectoral nerve block (PECS II) with ropivacaine before incision, for pain control after mastectomy | 2026-09-30 to 2026-09-30 | completed | S |
| Baseline bone density scan (DXA) before anastrozole: lumbar spine T-score -1.4, femoral neck T-score -1.7 (low bone mass) | 2026-10-19 to 2026-10-19 | completed | S |
| Aspiration of a right chest wall seroma by the breast surgery team: 140 mL of clear straw-colored fluid; no signs of infection | 2026-10-08 to 2026-10-08 | completed | S |
| Date | Vaccine | Status | Evidence |
|---|---|---|---|
| 2025-10-20 | Influenza vaccine, 2025-2026 season | completed | S |
| 2020-04-15 | Tdap vaccine | completed | S |
| 2026-10-29 | Influenza vaccine, 2026-2027 season | completed | S |
| 2026-10-29 | Pneumococcal conjugate vaccine PCV20 | completed | S |
| 2026-10-29 | Recombinant zoster vaccine, dose 1 of 2 | completed | S |
Historical biography with true dates. These events are not part of the synthetic care timeline.
| Historical date | History | Evidence |
|---|---|---|
| December 1794 | One pregnancy; her only child born when she was 42 | D (CLM-0003) |
| About August 1810 | A small, heavy pain in the breast from about August 1810, increasing week by week, treated for months without success, with a hardening of the affected spot and her right arm kept from use; the breast was not discolored | D (CLM-0005) |
| Relative | Condition | Age at death | Evidence |
|---|---|---|---|
| mother | Died in 1762, when Burney was about ten; cause not recorded in the cited source | D (CLM-0002) |
| Concern | Status | Evidence |
|---|---|---|
| A heavy, dull ache in the right breast for about a year and a firm lump she noticed two months ago | active | S |
| Dreads an operation; wants every step explained in advance and to be warned before anything is done | active | S |
Most recent measures: Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] 0 on 2026-10-29; Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] 5 on 2026-08-24; Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ] 7 on 2026-08-24; Cholesterol [Mass/volume] in Serum or Plasma 214 on 2026-10-19; Cholesterol in HDL [Mass/volume] in Serum or Plasma 58 on 2026-10-19; Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation 132 on 2026-10-19; Triglyceride [Mass/volume] in Serum or Plasma 120 on 2026-10-19; 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Mass/volume] in Serum or Plasma 24 on 2026-10-19; DXA Lumbar spine [T-score] Bone density -1.4 on 2026-10-19; DXA Femur [T-score] Bone density -1.7 on 2026-10-19; Total score [AUDIT-C] 2 on 2026-10-29 [S]
Strengths and supports: Supports: her husband and son and a wide circle of friends who visit often [S]
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| Invasive ductal carcinoma of the right breast, upper outer quadrant at 10 o'clock, presenting as a firm lump after about a year of breast ache; core biopsy: grade 2, estrogen and progesterone receptor positive, HER2 negative; clinical stage T2 N0 (cT2 cN0 M0); synthetic modern diagnosis linked to the documented 1811 breast disease and mastectomy, whose cancer diagnosis is debated | active | confirmed | C50.411 | S — Synthetic diagnosis confirmed by biopsy and surgical pathology in the modern episode; whether her historical disease was cancer remains a retrospective interpretation (R). |
| Estrogen receptor positive status of the breast cancer (ER 95 percent, PR 70 percent) | active | confirmed | Z17.0 | S — Synthetic receptor result; no tissue from her lifetime was examined. |
| Absence of the right breast after total mastectomy without reconstruction, her choice | active | confirmed | Z90.11 | S — Synthetic coding of the modern mastectomy, which echoes the documented operation. |
| Long-term use of anastrozole as adjuvant endocrine therapy | active | confirmed | Z79.811 | S — Synthetic treatment status. |
| Low bone mass (osteopenia) on baseline DXA before anastrozole: lumbar spine T-score -1.4, femoral neck -1.7; 10-year major osteoporotic fracture risk about 8 percent (FRAX); vitamin D insufficiency | active | confirmed | M85.80 | S — Synthetic finding on the baseline DXA the protocol requires for an aromatase inhibitor. |
| Seroma under the right mastectomy flap after drain removal, without infection; aspirated once by the breast surgery team; resolved | resolved | confirmed | L76.34 | S — Synthetic common complication of the synthetic mastectomy; it does not echo a documented illness. |
| Firm lump in the upper outer quadrant of the right breast after about a year of heavy breast ache; clinically suspicious, imaging and biopsy booked | resolved | confirmed | N63.11 | S — Synthetic presenting concern at the index visit, superseded by the biopsy diagnosis; the year of breast ache echoes her documented account (D). |
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
|---|---|---|---|---|---|---|
| 2026-08-10 | Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] | 1 | {score} | S | ||
| 2026-08-24 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 5 | {score} | S | ||
| 2026-08-24 | Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ] | 7 | {score} | S | ||
| 2026-10-19 | Cholesterol [Mass/volume] in Serum or Plasma | 214 | mg/dL | <=199 mg/dL | High | S |
| 2026-10-19 | Cholesterol in HDL [Mass/volume] in Serum or Plasma | 58 | mg/dL | >=50 mg/dL | Normal | S |
| 2026-10-19 | Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation | 132 | mg/dL | <=99 mg/dL | High | S |
| 2026-10-19 | Triglyceride [Mass/volume] in Serum or Plasma | 120 | mg/dL | <=149 mg/dL | Normal | S |
| 2026-10-19 | 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Mass/volume] in Serum or Plasma | 24 | ng/mL | 30-100 ng/mL | Low | S |
| 2026-10-19 | Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] | 1 | {score} | S | ||
| 2026-10-19 | DXA Lumbar spine [T-score] Bone density | -1.4 | {T-score} | >=-1 | Low | S |
| 2026-10-19 | DXA Femur [T-score] Bone density | -1.7 | {T-score} | >=-1 | Low | S |
| 2026-10-29 | Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] | 0 | {score} | S | ||
| 2026-10-29 | Total score [AUDIT-C] | 2 | {score} | S |
| Date | Measure | Value | Unit | Provenance |
|---|---|---|---|---|
| 2026-08-10 | Body height | 160 | cm | S |
| 2026-08-10 | Body weight | 62 | kg | S |
| 2026-08-10 | Body mass index (BMI) [Ratio] | 24.2 | kg/m2 | S |
| 2026-08-10 | Systolic blood pressure | 128 | mm[Hg] | S |
| 2026-08-10 | Diastolic blood pressure | 80 | mm[Hg] | S |
| 2026-08-10 | Heart rate | 82 | /min | S |
| 2026-08-10 | Respiratory rate | 14 | /min | S |
| 2026-08-10 | Body temperature | 36.7 | Cel | S |
| 2026-08-10 | Oxygen saturation in Arterial blood by Pulse oximetry | 99 | % | S |
| 2026-08-24 | Body height | 160 | cm | S |
| 2026-08-24 | Body weight | 61.6 | kg | S |
| 2026-08-24 | Body mass index (BMI) [Ratio] | 24.1 | kg/m2 | S |
| 2026-08-24 | Systolic blood pressure | 132 | mm[Hg] | S |
| 2026-08-24 | Diastolic blood pressure | 82 | mm[Hg] | S |
| 2026-08-24 | Heart rate | 86 | /min | S |
| 2026-08-24 | Respiratory rate | 14 | /min | S |
| 2026-08-24 | Body temperature | 36.6 | Cel | S |
| 2026-08-24 | Oxygen saturation in Arterial blood by Pulse oximetry | 99 | % | S |
| 2026-10-19 | Body height | 160 | cm | S |
| 2026-10-19 | Body weight | 60.9 | kg | S |
| 2026-10-19 | Body mass index (BMI) [Ratio] | 23.8 | kg/m2 | S |
| 2026-10-19 | Systolic blood pressure | 122 | mm[Hg] | S |
| 2026-10-19 | Diastolic blood pressure | 76 | mm[Hg] | S |
| 2026-10-19 | Heart rate | 74 | /min | S |
| 2026-10-19 | Respiratory rate | 14 | /min | S |
| 2026-10-19 | Body temperature | 36.6 | Cel | S |
| 2026-10-19 | Oxygen saturation in Arterial blood by Pulse oximetry | 99 | % | S |
| 2026-10-08 | Body height | 160 | cm | S |
| 2026-10-08 | Body weight | 60.8 | kg | S |
| 2026-10-08 | Body mass index (BMI) [Ratio] | 23.7 | kg/m2 | S |
| 2026-10-08 | Systolic blood pressure | 124 | mm[Hg] | S |
| 2026-10-08 | Diastolic blood pressure | 78 | mm[Hg] | S |
| 2026-10-08 | Heart rate | 80 | /min | S |
| 2026-10-08 | Respiratory rate | 14 | /min | S |
| 2026-10-08 | Body temperature | 36.9 | Cel | S |
| 2026-10-08 | Oxygen saturation in Arterial blood by Pulse oximetry | 99 | % | S |
| 2026-10-29 | Body height | 160 | cm | S |
| 2026-10-29 | Body weight | 61.2 | kg | S |
| 2026-10-29 | Body mass index (BMI) [Ratio] | 23.9 | kg/m2 | S |
| 2026-10-29 | Systolic blood pressure | 120 | mm[Hg] | S |
| 2026-10-29 | Diastolic blood pressure | 76 | mm[Hg] | S |
| 2026-10-29 | Heart rate | 72 | /min | S |
| 2026-10-29 | Respiratory rate | 14 | /min | S |
| 2026-10-29 | Body temperature | 36.6 | Cel | S |
| 2026-10-29 | Oxygen saturation in Arterial blood by Pulse oximetry | 99 | % | S |
| Date | Purpose | Status | Provenance |
|---|---|---|---|
| 2026-08-10 | Primary care visit for a right breast lump and a year of breast ache | finished | S |
| 2026-08-24 | Review of mammogram, ultrasound, and core biopsy showing breast cancer; breast surgery consultation | finished | S |
| 2026-10-19 | Review three weeks after right mastectomy; start of endocrine therapy and survivorship care | finished | S |
| 2026-10-08 | Same-day sick visit for swelling under the mastectomy scar | finished | S |
| 2026-10-29 | Adult preventive visit | finished | S |
| Intervention | Status | Guideline | Provenance |
|---|---|---|---|
| Diagnostic mammography and ultrasound, then image-guided core biopsy with ER, PR, and HER2 testing, for a palpable breast mass in a woman of 59 | completed | GL-NCCN-BREAST-2025, GL-CMID-2026 | S |
| Breast surgery consultation to discuss surgical options, imaging of the extent of disease, axillary staging, and anesthesia and pain control | completed | GL-NCCN-BREAST-2025 | S |
| Germline genetic testing before surgery, as recommended for breast cancer diagnosed at 65 or younger | completed | GL-ASCO-SSO-GERM-2024 | S |
| Right total mastectomy with sentinel lymph node biopsy under general anesthesia with a pectoral nerve block and an opioid-sparing recovery pathway | completed | GL-NCCN-BREAST-2025 | S |
| Anastrozole 1 mg daily for five years, with a baseline DXA repeated every two years, vitamin D and calcium, lipid monitoring, and questions about joint pain, hot flashes, and vaginal symptoms at every visit | completed | GL-ASCO-ENDO-2019, GL-CMID-2026 | S |
| Survivorship care: history and examination every 3 to 6 months for 3 years and a yearly mammogram of the left breast, with no routine blood tests or body imaging; lymphedema counseling and shoulder exercises; distress screening; a written survivorship care plan | completed | GL-CMID-2026, GL-ACS-ASCO-SURV-2016, GL-ASCO-FU-2013 | S |
| Goal | Target | Status | Outcome | Provenance |
|---|---|---|---|---|
| Complete diagnosis, staging, and surgery within eight weeks of presentation | 2026-10-19 | completed | Core biopsy in four days, MRI and a second biopsy within four weeks, mastectomy at seven weeks | S |
| Surgery under anesthesia with pain controlled without opioids after discharge | 2026-10-19 | completed | Pain 2 out of 10 by the third day; no opioid after leaving hospital; acetaminophen stopped at two weeks | S |
| Start adjuvant endocrine therapy with a bone-health plan | 2026-10-19 | completed | Anastrozole started; baseline DXA shows low bone mass; vitamin D started | S |
| Regain full right shoulder movement and keep lymphedema risk low | 2026-10-29 | active | Shoulder flexion 165 degrees at four weeks, nearly full, with physical therapy under way; arm circumferences equal | S |